Altintaş A.Ayyildiz O.Atay A.E.Çil T.Müftüoğlu E.2024-04-242024-04-2420061306-133Xhttps://hdl.handle.net/11468/24257Hairy cell leukemia is a rare, clonal, chronic B cell lenfoproliferative disease characterized by splenomegaly and pancytopenia. Purine analogues are first-line choice of therapy. Although effectivity of treatment is established, relapses may occur. In this state, remission may achieved by a new cycle of 2-CdA or alternative modalities. In this report, we represented the results of our patients with HCL that were treated with 2-CdA and followed up in our center.trinfo:eu-repo/semantics/closedAccessCladribineHairy Cell LeukemiaArticle16267702-s2.0-33745745839N/A